Investors / United States / Intuitive Ventures
Intuitive Ventures
Corporate VC · United States · North America
Intuitive Ventures is the corporate venture arm of Intuitive Surgical, managing over $250M in assets to support early-stage startups. It invests in healthcare companies and provides portfolio teams with practical guidance drawn from its clinical, technical, regulatory, and commercial experience.
Invests inHealthcare & Biotech
In its own wordshealthcaremedical technologyroboticsearly stagecorporate venture
Your fit with Intuitive Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsIntuitive Ventures lists 17 checked portfolio companies on its own site and is named in 7 funding rounds. Its most frequent entry is Series B, 57% of the companies with a known first round. Its largest themes are Healthcare & Biotech (94%) and Fintech (6%). 77% of its companies are based in United States. It invests most often alongside Santé Ventures, 8VC and Beringea.
Counts come from funding rounds that name Intuitive Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Intuitive Ventures' whole history. Rounds on record name 7 companies; its own site lists 17. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 14% |
| Series B | 57% |
| Growth | 29% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 4 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 44th | 17 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 97th | 29% of companies confirmed by a round |
| Sector focus | 96th | 94% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Santé Ventures | 3 |
| 8VC | 2 |
| Beringea | 2 |
| DFJ Growth | 2 |
| Eclipse | 2 |
| F-Prime Capital | 2 |
| Lightstone Ventures | 2 |
| Star51 Capital | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers17100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 94% | 15% |
| Fintech | 6% | 12% |
Co-investor network
who it backs companies with, and who they back togetherCompare Intuitive Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Intuitive Ventures| Date | Company | Stage |
|---|---|---|
| 28 Jan 2026 | Series C+ | |
| 8 Jan 2026 | Series B | |
| 12 Dec 2025 | Series A | |
| 18 Nov 2025 | Series B | |
| 4 Nov 2025 | Series B | |
| 7 Aug 2025 | Series B | |
| 11 Dec 2024 | Series C+ |
Round details for Intuitive Ventures
Amounts, full round histories and every co-investor in Intuitive Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
17 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Amber Therapeutics is developing the first adaptive neuromodulation therapy to treat women suffering with mixed urinary incontinence | Healthcare & Biotech | Portfolio page | ||
| Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding nitinol scaffold to improve lung function and breathing capacity. | Healthcare & Biotech | Aug 2025Series B | Page + round | |
| Capstan Medical develops and provides a less invasive treatment for heart valve disease using surgical robotics and catheter-based technology. | Healthcare & Biotech | Dec 2024Series C+ | Page + round | |
| Cellares manufactures cell therapies and provides related services and technologies | Healthcare & Biotech | Jan 2026Series C+ | Page + round | |
| Portfolio page | ||||
| Endogenex develops a system to treat type 2 diabetes using energy delivery in the small intestine to reset the body's metabolic signaling system | Healthcare & Biotech | Portfolio page | ||
| Flywheel provides a platform for managing medical imaging data and automating research workflows. | Healthcare & Biotech | Portfolio page | ||
| KelaHealth improves the surgical journey for patients and providers by delivering insights from millions of patients through an AI-enabled API. | Healthcare & Biotech | Portfolio page | ||
| Medcrypt helps medical device manufacturers with cybersecurity submissions for FDA approval | Healthcare & Biotech | Portfolio page | ||
| Neocis provides a robotic system to assist clinicians with dental implant surgery | Healthcare & Biotech | Portfolio page | ||
| Optellum develops AI-powered solutions for early lung cancer diagnosis | Healthcare & Biotech | Jan 2026Series B | Page + round | |
| OrganOx develops technologies to enhance organ transplantation, including normothermic machine perfusion | Healthcare & Biotech | Portfolio page | ||
| Saladin provides an online insurance platform for Vietnamese people to buy and manage insurance policies | FintechHealthcare & Biotech | Dec 2025Series A | Funding round | |
| Sovato develops a platform for remote robotic surgery and procedures | Healthcare & Biotech | Nov 2025Series B | Funding round | |
| SURGE Therapeutics seeks to change the standard of care for cancer patients by transforming how, when, and where cancer immunotherapy is deployed | Healthcare & Biotech | Portfolio page | ||
| VahatiCor develops a device to treat coronary microvascular dysfunction | Healthcare & Biotech | Nov 2025Series B | Page + round | |
| XII Medical develops therapies for Obstructive Sleep Apnea | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- intuitive.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 11 Dec 2024
- Companies checked
- 17
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Intuitive Ventures' profile as data
Pull Intuitive Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/intuitive.com
# also
GET /v1/firms/intuitive.com/portfolio
GET /v1/firms/intuitive.com/coinvestors
GET /v1/firms/intuitive.com/news